Alpine Global Management’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-32,500
Closed -$4.31M – 256
2026
Q2
$4.31M Buy
+32,500
New +$2.93M 0.7% 19

Other funds holding APGE

Alpine Global Management's APGE Position: Q3 2026 in Review

Alpine Global Management sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 32,500 shares — an estimated $4.31M sold.

Alpine Global Management first reported a position in APGE in Q2 2026 and held it in 1 quarter. The position peaked at $4.31M in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.

  • Alpine Global Management reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Alpine Global Management sold 32,500 Apogee Therapeutics shares in Q3 2026, an estimated $4.31M.
  • Alpine Global Management first reported a position in Apogee Therapeutics in Q2 2026 and held it in 1 quarter.
  • Alpine Global Management's Apogee Therapeutics position peaked at $4.31M in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.

Based on Alpine Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.